Signati Medical™ Receives Additional Patent Protection for its Innovative Bipolar Handpiece
September 28, 2023 09:00 ET
|
Signati Medical Inc.
Providence, RI, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Signati Medical™ is pleased to announce the issue of US patent 11,723,680 covering critical features of the bipolar handpiece used in Signati’s...
Signati™ Medical Files IDE Study with FDA
September 26, 2023 09:00 ET
|
Signati Medical Inc.
Providence, RI, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Signati™ Medical has officially filed their IDE study with the FDA. An Investigational Device Exemption (IDE) allows the investigational device to...
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...
Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)
August 10, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals (Marius) and Smartway Pharmaceuticals (Smartway) are pleased to announce their strategic partnership, aimed at addressing the...
Signati™️ Medical, Inc. Announces Dr. LeRoy Jones Has Been Appointed to Its Board of Directors
August 03, 2023 09:00 ET
|
Signati Medical Inc.
Providence, RI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed to its Board of Directors. Dr. Jones is considered an authority in...
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
July 24, 2023 09:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or Testosterone Deficiency, is proud to...
Cepham’s Prosprune Protects Men and Sustains the Environment in the Name of Prostate Health
July 18, 2023 08:28 ET
|
Cepham
CHANDIGARH, India, July 18, 2023 (GLOBE NEWSWIRE) -- Researchers at Cepham, an innovative leader in nutraceuticals research and branded ingredients, have developed a patent-pending hydro-ethanolic...
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
June 09, 2023 10:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...
81% of Canadian men surveyed believe physical activity has a positive effect on their mental health
June 01, 2023 08:00 ET
|
Canadian Men's Health Foundation
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) -- Canadian men and their families are encouraged to become more physically active to improve their mental well-being in June...
Mangoceuticals to Ring NASDAQ Stock Market Closing Bell on May 18
May 18, 2023 09:15 ET
|
Mangoceuticals, Inc.
DALLAS, TX, May 18, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and...